Federico Grossi
Director/Board Member bij Endoprotech, Inc.
Vermogen: 6 M $ op 31-03-2024
Profiel
Federico Grossi bekleedt de functie van Chief Medical Officer bij Apellis Pharmaceuticals, Inc. Hij zit ook in de raad van bestuur van Endoprotech, Inc. In het verleden was Dr. Grossi Director-Clinical Research bij Potentia Pharmaceuticals, Inc., Executive Vice President voor Potentia Pharmaceuticals, Inc. en Lid-Face Transplant Team aan de Universiteit van Louisville. Hij behaalde een graduaat en een doctoraat aan de Universiteit van Louisville en een doctoraat aan de Nationale Universiteit van Cordoba.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-01-2023 | 94 884 ( 0.08% ) | 6 M $ | 31-03-2024 |
Actieve functies van Federico Grossi
| Bedrijven | Functie | Begin |
|---|---|---|
Endoprotech, Inc.
 Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Director/Board Member | - |
Eerdere bekende functies van Federico Grossi
| Bedrijven | Functie | Einde |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 03-01-2023 |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Corporate Officer/Principal | 01-09-2014 |
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Chief Tech/Sci/R&D Officer | 01-04-2010 |
| University of Louisville | Corporate Officer/Principal | - |
Opleiding van Federico Grossi
| University of Louisville | Doctorate Degree |
| National University of Cordoba | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Endoprotech, Inc.
Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Distribution Services |
